|
Office of Biotechnology Activities
|
National Institutes of Health - Office of Science Policy
|
| |
| RAC March 11, 2004 - Presentation Materials |
|
| 95th Meeting Day 3 |
| Bethesda, Maryland |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Call to Order and Opening Remarks |
|
|
| |
Diane Wara, M.D., Chair, NIH RAC |
|
|
| |
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0401-623 |
|
|
| |
A Phase I/II Dose-Escalating Randomized Controlled Study to Assess the Safety, Tolerability, and Efficacy of CERE-110 [Adeno-Associated Virus (AAV)-Based, Vector-Mediated Delivery of Beta-Nerve Growth Factor (NGF)] in Subjects with Mild to Moderate Alzheimer's Disease |
|
|
| |
Webcast
Intro Slides
|
|
|
| |
David A. Bennett, M.D., Rush University Medical Center, Chicago, IL |
|
|
| |
Slides
|
|
|
| |
Raymond T. Bartus, Ph.D. |
|
|
| |
Slides
|
|
| |
|
|
|
RAC Recommendations |
|
|
| |
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0401-622: |
|
|
| |
Adenylyl Cyclase VI Gene Transfer for Congenital Heart Failure |
|
|
| |
H. Kirk Hammond, M.D., University of California, San Diego |
|
|
| |
Webcast
Slides
|
|
|
| |
Walter J. Koch, Ph.D., Jefferson Medical College, Philadelphia, PA |
|
|
| |
Slides
|
|
| |
|
|
|
RAC Recommendations |
|
|
| |
Webcast
|
|
| |
|
|
|
ADJOURN |
|
| |
|
Top of Page |
| |
|
|
|
|
|
|